Linical Co., Ltd. (2183.T)
JPY 330.0
(0.92%)
JPY 330.0
(0.92%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.49 Billion JPY | -37.56% |
| 2022 | 2.4 Billion JPY | -18.97% |
| 2021 | 2.96 Billion JPY | -16.3% |
| 2020 | 3.54 Billion JPY | 11.39% |
| 2019 | 3.17 Billion JPY | 2.45% |
| 2018 | 3.1 Billion JPY | 291.13% |
| 2017 | 793.47 Million JPY | -14.99% |
| 2016 | 933.44 Million JPY | -13.04% |
| 2015 | 1.07 Billion JPY | -11.54% |
| 2014 | 1.21 Billion JPY | 230.17% |
| 2013 | 367.5 Million JPY | -9.52% |
| 2012 | 406.17 Million JPY | -7.12% |
| 2011 | 437.32 Million JPY | -6.18% |
| 2010 | 466.15 Million JPY | 2847.52% |
| 2009 | 15.81 Million JPY | -38.3% |
| 2008 | 25.63 Million JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.39 Billion JPY | -6.73% |
| 2023 Q2 | 2.06 Billion JPY | -8.6% |
| 2023 FY | 1.49 Billion JPY | -37.56% |
| 2023 Q4 | 1.49 Billion JPY | -6.25% |
| 2023 Q3 | 1.59 Billion JPY | -22.69% |
| 2023 Q1 | 2.26 Billion JPY | -5.74% |
| 2022 Q1 | 2.85 Billion JPY | -3.67% |
| 2022 Q2 | 2.69 Billion JPY | -5.64% |
| 2022 Q3 | 2.54 Billion JPY | -5.72% |
| 2022 Q4 | 2.4 Billion JPY | -5.45% |
| 2022 FY | 2.4 Billion JPY | -18.97% |
| 2021 Q2 | 3.14 Billion JPY | -7.26% |
| 2021 Q1 | 3.39 Billion JPY | -4.23% |
| 2021 Q3 | 3.09 Billion JPY | -1.52% |
| 2021 Q4 | 2.96 Billion JPY | -4.31% |
| 2021 FY | 2.96 Billion JPY | -16.3% |
| 2020 FY | 3.54 Billion JPY | 11.39% |
| 2020 Q2 | 2.95 Billion JPY | -3.77% |
| 2020 Q1 | 3.06 Billion JPY | -3.52% |
| 2020 Q3 | 2.83 Billion JPY | -3.85% |
| 2020 Q4 | 3.54 Billion JPY | 24.77% |
| 2019 FY | 3.17 Billion JPY | 2.45% |
| 2019 Q4 | 3.17 Billion JPY | -3.75% |
| 2019 Q1 | 3.3 Billion JPY | 6.38% |
| 2019 Q3 | 3.3 Billion JPY | -1.5% |
| 2019 Q2 | 3.35 Billion JPY | 1.57% |
| 2018 Q1 | 758.48 Million JPY | -4.41% |
| 2018 FY | 3.1 Billion JPY | 291.13% |
| 2018 Q4 | 3.1 Billion JPY | -3.27% |
| 2018 Q3 | 3.2 Billion JPY | 343.47% |
| 2018 Q2 | 723.48 Million JPY | -4.61% |
| 2017 Q4 | 793.47 Million JPY | -4.22% |
| 2017 Q1 | 898.44 Million JPY | -3.75% |
| 2017 FY | 793.47 Million JPY | -14.99% |
| 2017 Q2 | 863.45 Million JPY | -3.89% |
| 2017 Q3 | 828.46 Million JPY | -4.05% |
| 2016 Q4 | 933.44 Million JPY | -3.61% |
| 2016 Q1 | 1.03 Billion JPY | -3.26% |
| 2016 FY | 933.44 Million JPY | -13.04% |
| 2016 Q2 | 1 Billion JPY | -3.37% |
| 2016 Q3 | 968.43 Million JPY | -3.49% |
| 2015 Q2 | 1.14 Billion JPY | -2.97% |
| 2015 Q4 | 1.07 Billion JPY | -3.16% |
| 2015 Q1 | 1.17 Billion JPY | -2.88% |
| 2015 FY | 1.07 Billion JPY | -11.54% |
| 2015 Q3 | 1.1 Billion JPY | -3.06% |
| 2014 FY | 1.21 Billion JPY | 230.17% |
| 2014 Q1 | 360 Million JPY | -2.04% |
| 2014 Q4 | 1.21 Billion JPY | -2.8% |
| 2014 Q3 | 1.24 Billion JPY | 254.15% |
| 2014 Q2 | 352.5 Million JPY | -2.08% |
| 2013 Q3 | 386.13 Million JPY | -1.92% |
| 2013 Q4 | 367.5 Million JPY | -4.83% |
| 2013 FY | 367.5 Million JPY | -9.52% |
| 2013 Q1 | 402.53 Million JPY | -0.9% |
| 2013 Q2 | 393.7 Million JPY | -2.19% |
| 2012 Q1 | 432.44 Million JPY | -1.12% |
| 2012 Q2 | 423.63 Million JPY | -2.04% |
| 2012 Q3 | 414.93 Million JPY | -2.05% |
| 2012 Q4 | 406.17 Million JPY | -2.11% |
| 2012 FY | 406.17 Million JPY | -7.12% |
| 2011 Q1 | 456.5 Million JPY | -2.07% |
| 2011 FY | 437.32 Million JPY | -6.18% |
| 2011 Q2 | 452.34 Million JPY | -0.91% |
| 2011 Q3 | 443.28 Million JPY | -2.0% |
| 2011 Q4 | 437.32 Million JPY | -1.34% |
| 2010 Q3 | 476.18 Million JPY | 3353.65% |
| 2010 Q4 | 466.15 Million JPY | -2.11% |
| 2010 FY | 466.15 Million JPY | 2847.52% |
| 2010 Q2 | 13.78 Million JPY | 0.0% |
| 2009 Q1 | 24.68 Million JPY | -3.7% |
| 2009 FY | 15.81 Million JPY | -38.3% |
| 2009 Q4 | 15.81 Million JPY | -13.86% |
| 2009 Q3 | 18.35 Million JPY | -14.51% |
| 2009 Q2 | 21.47 Million JPY | -13.0% |
| 2008 Q4 | 25.63 Million JPY | 0.0% |
| 2008 FY | 25.63 Million JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 767.03 Million JPY | -95.552% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 2 Billion JPY | 25.003% |
| Trans Genic Inc. | 1.32 Billion JPY | -13.027% |
| MEDINET Co., Ltd. | 781 Thousand JPY | -191955.058% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.34 Billion JPY | 36.093% |
| AnGes, Inc. | 214.94 Million JPY | -597.817% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -1303.803% |
| Nxera Pharma Co., Ltd. | 63.21 Billion JPY | 97.627% |
| Immuno-Biological Laboratories Co., Ltd. | 84.56 Million JPY | -1673.808% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | -35.263% |
| Carna Biosciences, Inc. | 28.4 Million JPY | -5181.142% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 875.59 Million JPY | -71.306% |
| RaQualia Pharma Inc. | 39.05 Million JPY | -3741.101% |
| Chiome Bioscience Inc. | - JPY | -Infinity% |
| Kidswell Bio Corporation | 1.83 Billion JPY | 18.39% |
| PeptiDream Inc. | 19.63 Billion JPY | 92.361% |
| Oncolys BioPharma Inc. | 161.1 Million JPY | -831.068% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 397 Million JPY | -277.821% |
| Healios K.K. | 450 Million JPY | -233.322% |
| BrightPath Biotherapeutics Co., Ltd. | - JPY | -Infinity% |
| Kubota Pharmaceutical Holdings Co., Ltd. | - JPY | -Infinity% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 77.29 Million JPY | -1840.653% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 773.29 Million JPY | -93.969% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 788 Million JPY | -90.349% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 491.35 Million JPY | -205.271% |
| StemCell Institute Inc. | 6.67 Million JPY | -22367.795% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 143.75 Million JPY | -943.443% |